The given statement is True. In Parkinson's disease, dopamine-producing neurons are deficient in the brain.
<h3>
What is parkinson's disease?</h3>
Parkinson's disease is a progressive disorder that is caused by the degeneration of nerve cells. In this disease, the substance called nigra starts degrading which controls the movement in the body.
This cell stops producing an important chemical called dopamine. Dopamine helps in coordination with nerve cells and muscle cells. Dopamine deficiency leads to:
- Rigidity
- Slowness of movement
- Impaired balance and coordination.
The main cause of Parkinson's disease is genetic factors and environmental factors. The most common medicine given is levodopa. This is the standard medicine given to the patient.
Therefore, The given statement is True. In Parkinson's disease, dopamine-producing neurons are deficient in the brain.
To learn more about parkinson's disease, refer to the link:
brainly.com/question/26431892
#SPJ4
Answer:
The correct answer is b) "We are worried that our child may have other congenital problems that we aren't aware of."
Explanation:
This malformation is associated with other congenital problems, such as heart problems, spinal problems, renal problems due to malformation of kidneys, fistulas in the colon, or tracheoesophageal fistula. When the parents said "We are worried that our child may have other congenital problems that we aren't aware of." the nurse has informed the parents about other possible congenital problems and they understood it, that is why they are worried.
In my opinion, an oncology patient should not be allowed to try an experimental treatment because it does not meet ethical guidelines. This situation is framed in a law known as 'Right to Try'.
All medical treatments must follow a series of clinical trials in order to assess the safety and effectiveness of the treatment.
The use of experimental treatment in patients seems unethical from any point of view.
However, the 'Right to Try' law is aimed at providing patients greater access to experimental therapies, and there are patient advocates who consider it will benefit patients.
In the USA, the Right-to-try law is aimed at allowing terminally ill patients access to different experimental therapies which completed only the first Phase testing and therefore have not been approved by the FDA.
Learn more in:
brainly.com/question/15818797?referrer=searchResults
Hemoglobin: The protien in red blood cells.
